Quick Answer
GeoVax Labs, Inc. reported Stockholders Equity of $5.05 million for fiscal year 2024.
GeoVax Labs, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $5.05M | -12.4% |
| 2023 | $5.76M | -78.3% |
| 2022 | $26.60M | +509.9% |
| 2021 | $4.36M | -54.4% |
| 2020 | $9.57M | +707.7% |
| 2019 | -$1.57M | -54.0% |
| 2018 | -$1.02M | -218.4% |
| 2017 | -$321.1K | -233.6% |
| 2016 | $240.4K | -80.0% |
| 2015 | $1.20M | +5.1% |
| 2014 | $1.15M | -54.6% |
| 2013 | $2.53M | +119.6% |
| 2012 | $1.15M | +63.6% |
| 2011 | $703.6K | -61.7% |
| 2010 | $1.84M | -51.0% |
| 2009 | $3.74M | +38.2% |
| 2008 | $2.71M | +2.3% |
| 2007 | $2.65M | +20.2% |
| 2006 | $2.20M | +540.1% |
| 2005 | -$500.6K | -28.5% |
| 2004 | -$389.5K | -144.6% |
| 2003 | $872.4K | +236.4% |
| 2002 | -$639.4K | -274.8% |
| 2001 | -$170.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.91M | -42.3% | +73.9% |
| June 30, 2025 | $2.82M | +222.2% | -64.3% |
| March 31, 2025 | $7.90M | +14451.9% | +56.4% |
| December 31, 2024 | $5.05M | -12.4% | -40.6% |
| September 30, 2024 | $8.50M | -6.7% | +468.3% |
| June 30, 2024 | -$2.31M | -113.5% | -4354.7% |
| March 31, 2024 | $54.3K | -99.8% | -99.1% |
| December 31, 2023 | $5.76M | -78.3% | -36.8% |
- GeoVax Labs, Inc. showed a decrease of -12.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2001–2024 period, GeoVax Labs, Inc.’s stockholders equity has grown by 3059.6% (from -$170.6 thousand to $5.05 million).
- The most recent figure is from GeoVax Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: